ResMed Inc. to Present at Upcoming Investor Conferences

Friday, September 18, 2009 General News J E 4
SAN DIEGO, Aug. 10 ResMed Inc. (NYSE: RMD) announced today that they will be presenting at three upcoming investor conferences.

Actual presentation times for the latter two conferences will be able to be found on our website in the "Investor" section under "Event Calendar" in the near future as they are confirmed.

The Company's presentations will be webcast. To access the live webcast or the archived webcast of the presentation, please log onto the Company's website at Further information can be obtained by contacting Constance Bienfait at ResMed Inc., San Diego, at +1(858) 836-5971 or by visiting the Company's multilingual Web site at

ResMed is a leading developer, manufacturer, and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. We are dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing.

-- Kieran Gallahue, President and CEO will be presenting at the Canaccord Adams Global Growth Conference at the Intercontinental Boston Hotel in Boston on August 12, 2009 at 9:00 a.m. US Eastern Time -- David Pendarvis, SVP, Organization Development and General Counsel will be presenting at the Morgan Stanley Global Healthcare Conference at the Grand Hyatt in NYC on September 15, 2009 -- David Pendarvis will present at the UBS Global Life Sciences Conference also at the Grand Hyatt in NYC on September 22, 2009

SOURCE ResMed Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
New Economic Study Exposes Faults in Controversial...
Mindray Announces Second Quarter 2009 Financial Re...